Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04464421 · ClinicalTrials.gov registry record · NA
SMART Effectiveness Trial
A NA study, sponsored by Karen Derefinko, PhD.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT04464421 is a NA study that has completed, run by Karen Derefinko, PhD. The registered enrollment target is 48 participants.
The verdict
NCT04464421, a NA study, has completed, sponsored by Karen Derefinko, PhD.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
The current study piloted two psychosocial interventions developed to increase buprenorphine-naloxone adherence in individuals with opioid use disorder (OUD). Participants were randomized to receive either contingency management (CM) or a brief substance free activities session plus mindfulness (BSM) cognitive-behavioral intervention. Participants were 48 newly presenting patients from an OUD treatment clinic. The primary outcome was medication adherence, as measured by buprenorphine metabolite in urine and presence at 2 or more of 4 possible physician visits.
Interventions
- BEHAVIORAL Contingency Management (CM)
- BEHAVIORAL Brief Motivational Intervention + Substance Free Activities Session + Mindfulness-Based Adherence Promotion (BSM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2020-08-17 |
| Est. Completion | 2021-08-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04464421
The ClinicalTrials.gov registry entry for NCT04464421 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Karen Derefinko, PhD, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Contingency Management (CM) is the first listed.
NCT04464421 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04464421 about?
NCT04464421 is a clinical study titled "SMART Effectiveness Trial". The current study piloted two psychosocial interventions developed to increase buprenorphine-naloxone adherence in individuals with opioid use disorder (OUD). Participants were randomized to receive either contingency management (CM) or a brief substance free activities session plus mindfulness (BSM...
What is the current status of trial NCT04464421?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2020-08-17. Estimated completion is 2021-08-29.
What interventions are being tested in trial NCT04464421?
The interventions under investigation include: Contingency Management (CM) (BEHAVIORAL), Brief Motivational Intervention + Substance Free Activities Session + Mindfulness-Based Adherence Promotion (BSM) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04464421?
This trial is sponsored by Karen Derefinko, PhD, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.